资讯
2 天
Stars Insider on MSNCholangiocarcinoma: the bile duct cancer with a low survival rateCholangiocarcinoma, also known as bile duct cancer, is a rare disease. It's a devastating condition incurable at the point ...
肝内胆管癌(intrahepatic cholangiocarcinoma, iCCA)的预后不佳,很大原因是由于诊断不够及时造成的,因此iCCA的早期诊断和及早治疗是提高疾病治愈效果的 ...
Intraductal neoplasms of the bile duct are macroscopically characterized by exophytic or polypoid growth patterns and have a favorable prognosis. Although some tumors with a predominantly tubular ...
7 天
Sportschosun on MSNDeveloping the world's first AI-based cholangiocarcinoma cell diagnosis technology ...Bile duct cancer cells and normal cells 3D photolithography image difference Bile duct cancer, a malignant tumor that occurs in the bile duct, is difficult to diagnose early because there are few ...
The aim of this study was to identify the pattern and significance of expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. Histological sections from 18 patients ...
With a baby on the way, Nathan Kirkland was facing a rare, aggressive form of bile duct cancer. Kirkland’s bills piled up as ...
The incidence of cholangiocarcinoma is modest in the western world, between 0.35 to 2 per 100,000 annually; however, in China and Thailand, the incidence can be up to 40 times the rate observed in the ...
The albumin-bilirubin (ALBI) score can independently predict prognosis in post-surgical patients with distal cholangiocarcinoma (dCCA), a form of cholangiocarcinoma (CCA), according to results ...
At the 2021 Cholangiocarcinoma Foundation Annual Conference, experts discussed guidelines and real-world data for the management of urgent symptoms in patients with cholangiocarcinoma who have ...
Cholangiocarcinoma (CCA) is a biliary tract malignancy with limited treatment options and a poor 5-year survival rate of < 20% after surgery and chemotherapy. 1 CCA can be classified into intrahepatic ...
Progress in cholangiocarcinoma treatment was long stalled, but now scientists are identifying genetic drivers likely to respond to novel drugs. A new understanding of the genetic mutations that drive ...
World Cholangiocarcinoma Day is on February 15. We will celebrate progress on better diagnostics, treatment options, early detection and cures.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果